SecBot SecBot
Insider Cluster (3 insiders) ·Filed Jul 16, 2026

PTCT

PTC THERAPEUTICS, INC.
NEUTRAL
Impact 3/10
Horizondays Processed4mo ago
Insider cluster: 3 insiders, $1.4M total
Actionable Insight • Neutral

The insider selling is immaterial relative to market cap and lacks a bearish catalyst. No cross-filing context (earnings, late filing, or agreement) amplifies the signal. Monitor for any upcoming regulatory or pipeline catalysts, but this cluster alone does not warrant a trading action.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$78.59
T+0 close · Jul 16, 2026 · via day close
Latest settled
−19.94%
T+60 · $62.92
Vs SPY
−24.62%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jul 17 $78.59entry
  2. T+1 · 4mo ago −0.74%α −0.58% · $78.01
  3. T+5 · 4mo ago −2.25%α −1.67% · $76.82
  4. T+20 · 3mo ago −8.77%α −13.21% · $71.70
  5. T+60 · 5w ago −19.94%α −24.62% · $62.92
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Three PTC Therapeutics insiders, including the CFO and Chief Technical Ops Officer, sold a total of $1.40M in stock over a one-week window. The sales are modest relative to the $6.5B market cap (0.02%) and are likely driven by routine portfolio diversification or tax planning, not a bearish signal on fundamentals.

Key Financial Metrics

Direction
selling
Total Value
$1.4M
Insiders
3

Key Facts

  • Three insiders sold shares totaling $1.40M between July 7-14, 2026.
  • CFO Pierre Gravier sold 3,494 shares at $80.35 for $280,743.
  • Chief Technical Ops Officer Neil Almstead sold 2,500 shares at $90.25 for $222,000.
  • Director Mary L. Smith sold 10,000 shares at $90.00 for $900,000.
  • Total sales represent approximately 0.02% of PTCT's $6.5B market cap.
  • No open-market purchases were reported in the cluster.

Financial Impact

Total insider sales of $1.40M represent 0.02% of market cap, trivial and routine.

insider holdings

Risk Factors

  • Insider sales could accelerate if a negative catalyst emerges (e.g., clinical trial failure, regulatory setback).
  • The CFO's sale at a lower price ($80.35) than the other two ($90.00-$90.25) may indicate a staggered exit, but the difference is within normal trading range.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
81% bullish (21 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-PTCT-1784275361376

Track record

29 reports on PTCT

Performance horizon

4 of 6 bullish or bearish reports moved the stock their way by T+1. Best: +19.01% at T+60 after the Apr 28, 2026 report. 5 of 6 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G Neutral 3/10 Entry $62.09 Now $60.97 −1.80% settles Nov 17
  2. Nov 16, 2026today 144 Neutral 2/10 Entry $62.10 Now $60.97 −1.82% settles Nov 17
  3. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $63.45 Now $60.97 −3.91% settles Nov 17
  4. Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $64.14 to $64.91 Now $60.97 −4.94% ▲ +1.20% −0.12% vs SPY
  5. Nov 3, 202613d ago 8-K Neutral 3/10 Entry $68.12 to $68.97 Now $60.97 −10.50% ▲ +1.25% −0.40% vs SPY
  6. Nov 3, 202613d ago Press Release Neutral 3/10 Entry $68.12 to $68.97 Now $60.97 −10.50% ▲ +1.25% −0.40% vs SPY
  7. Nov 2, 202614d ago Institutional Cluster Bearish 4/10 Entry $68.12 to $68.97 Now $60.97 +10.50% ▼ −1.25% +0.40% vs SPY
  8. Oct 29, 202618d ago 8-K Bullish 6/10 Entry $59.97 to $60.88 Now $60.97 +1.67% ▲ +1.52% +2.00% vs SPY
  9. Oct 27, 202620d ago Institutional Cluster Mixed 3/10 Entry $63.02 to $64.46 Now $60.97 −3.25% ▲ +2.29% +2.67% vs SPY
  10. Oct 16, 20264w ago Insider Cluster Neutral 3/10 Entry $61.53 to $62.92 Now $60.97 −0.91% ▲ +2.26% +1.92% vs SPY
Showing 10 of 29

US Market Status

Market Closed · Opens in 6h 41m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 17, 2026